Wanling Y. Sun
No. 45 Changchun Street
Beijing, 100053, China
Beijing, 100053, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 42 publications
Case Report: Long-term survival of refractory high-grade B-cell lymphoma with MYC, BCL2, and BCL6 rearrangements through glofitamab monotherapy consolidated by ASCT.
Journal: Frontiers in immunology
Published: April 16, 2026
Smoldering Waldenström macroglobulinemia coexisting with myelodysplastic syndrome: a rare case report and literature review.
Journal: Frontiers in oncology
Published: April 08, 2026
Primary sinonasal DLBCL: High prevalence of MCD subtype and CNS risk.
Journal: Annals of the Academy of Medicine, Singapore
Published: April 01, 2026
Efficacy and safety of Ruxolitinib-based combination therapy in the patients with Myelofibrosis (MF): a systematic review and meta-analysis.
Journal: Annals of medicine
Published: February 28, 2026
Real-world comparison of BTK inhibitors and lenalidomide as first-line maintenance in primary CNS lymphoma: a multi-center retrospective study.
Journal: Journal of neuro-oncology
Published: January 29, 2026
A Rare Case of Pediatric BRAF V600E-Mutated Erdheim-Chester Disease With Isolated Central Nervous System Onset: Diagnosis, Treatment, and Efficacy Evaluation.
Journal: Pediatric blood & cancer
Published: December 17, 2025
Initiation timing and treatment duration of eltrombopag added to immunosuppressive therapy in aplastic anemia: a systematic review and meta-analysis.
Journal: Frontiers in oncology
Published: December 12, 2025
Bone Marrow Failure Model Mimics Aplastic Anemia Patients: Single-Cell Landscape of Immune Response Reveals Novel Mechanisms of Immune Imbalance in AA.
Journal: Cancer medicine
Published: November 26, 2025
The Role of IFN-γ-Mediated Immune Cell Crosstalk in the Pathogenesis of Aplastic Anemia.
Journal: Journal of immunology research
Published: October 29, 2025
Vitamin C attenuates primate bone marrow aging at the molecular and progenitor level.
Journal: Cell stem cell
Published: August 01, 2025
Ibrutinib combined with rituximab and high-dose methotrexate in newly diagnosed primary CNS diffuse large B-cell lymphoma: a pilot study with long-term follow-up.
Journal: Frontiers in oncology
Published: July 19, 2025
Lenalidomide-rituximab with high-dose methotrexate for treatment of patients with newly diagnosed primary cns lymphoma: a promising first-line approach.
Journal: Annals of hematology
Published: July 08, 2025
Last Updated: 09/26/2026